Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience by Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino

Get full text